NutriSystem (NTRI) Stock Rating Upgraded by Barrington Research

NutriSystem (NASDAQ:NTRI) was upgraded by equities research analysts at Barrington Research from a “market perform” rating to an “outperform” rating in a research note issued to investors on Thursday, Marketbeat.com reports. The firm presently has a $44.00 price objective on the stock. Barrington Research’s price target points to a potential upside of 18.89% from the stock’s previous close.

The analysts wrote, “We are upgrading our investment rating to OUTPERFORM with a price target of $44, which assumes a conservative 10x EV/adjusted EBITDA multiple and a 16.5x P/E multiple.””

Other research analysts have also recently issued reports about the company. ValuEngine raised NutriSystem from a “strong sell” rating to a “sell” rating in a research note on Thursday. DA Davidson raised NutriSystem from an “underperform” rating to a “neutral” rating and raised their price objective for the company from $28.00 to $36.00 in a research note on Thursday. B. Riley raised their price objective on NutriSystem from $52.00 to $53.00 and gave the company a “buy” rating in a research note on Tuesday, July 31st. Zacks Investment Research raised NutriSystem from a “hold” rating to a “buy” rating and set a $45.00 price objective on the stock in a research note on Thursday, August 2nd. Finally, BidaskClub cut NutriSystem from a “hold” rating to a “sell” rating in a research note on Saturday, August 18th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $45.57.

NASDAQ NTRI traded up $1.45 during trading hours on Thursday, reaching $37.01. 12,915 shares of the stock traded hands, compared to its average volume of 866,335. NutriSystem has a 1 year low of $26.06 and a 1 year high of $55.10. The company has a market capitalization of $982.25 million, a price-to-earnings ratio of 18.92, a PEG ratio of 1.62 and a beta of 1.27.

NutriSystem (NASDAQ:NTRI) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $0.54 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.54. NutriSystem had a return on equity of 44.33% and a net margin of 8.06%. The firm had revenue of $159.30 million for the quarter, compared to analysts’ expectations of $164.18 million. During the same period last year, the firm earned $0.49 earnings per share. The company’s revenue for the quarter was up .8% compared to the same quarter last year. Analysts expect that NutriSystem will post 2.06 earnings per share for the current year.

NutriSystem declared that its Board of Directors has initiated a share buyback plan on Tuesday, October 30th that authorizes the company to buyback $75.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 7.7% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s management believes its shares are undervalued.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Moody Aldrich Partners LLC bought a new stake in shares of NutriSystem in the third quarter worth about $2,375,000. Frontier Capital Management Co. LLC grew its stake in shares of NutriSystem by 41.3% in the third quarter. Frontier Capital Management Co. LLC now owns 602,313 shares of the company’s stock worth $22,316,000 after purchasing an additional 176,003 shares during the last quarter. OLD National Bancorp IN bought a new stake in shares of NutriSystem in the third quarter worth about $315,000. Russell Investments Group Ltd. grew its stake in shares of NutriSystem by 75.2% in the third quarter. Russell Investments Group Ltd. now owns 52,310 shares of the company’s stock worth $1,938,000 after purchasing an additional 22,455 shares during the last quarter. Finally, First Trust Advisors LP bought a new stake in shares of NutriSystem in the third quarter worth about $2,118,000.

NutriSystem Company Profile

Nutrisystem, Inc, together with its subsidiaries, provides weight management products and services for women and men in the United States. The company offers weight loss programs that consist primarily of a pre-packaged food program, digital tools, and counseling. It also provides Nutrisystem Lean13 program, which provides weight loss, and support and counseling services; the South Beach Diet, a weight-loss program; and Nutrisystem 5-day kit, a ‘D' kit that offers individuals with or at risk of type 2 diabetes.

Further Reading: Conference Calls

Analyst Recommendations for NutriSystem (NASDAQ:NTRI)

Receive News & Ratings for NutriSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NutriSystem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply